Brief: Bcal Diagnostics Seeks Trading Halt
29/05/2024 06:02
May 29 (Reuters) - BCAL Diagnostics Ltd BDX.AX :
* SEEKS TRADING HALT PENDING CO'S RESPONSE TO AN ASX PRICE
QUERY
LETTER
Further company coverage: BDX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BCAL Diagnostics
See all newsAustralia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: BCAL Diagnostics Introduces Avantect Multi-Cancer Early Detection Test
Brief: BCAL Diagnostics Clarifies Of Bcal's Position In Relation To Genetic Signatures
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: BCAL To Acquire Shares In Genetic Signatures